Impact of positron emission tomography/computed tomography in the management of patients with epithelial ovarian carcinoma after treatment

Archives of Gynecology and Obstetrics

Volumn 283, Issue 5, 2011, Pages 1121-1126

  Nasu, Kaei ^a   Abe, Wakana ^a   Takai, Noriyuki ^a   Tomonari, Kenichiro ^b   Narahara, Hisashi ^a  

^a OITA UNIVERSITY   (Japan)

^b Oita Diagnostic Imaging Center   (Japan)

Author keywords

Contrast enhanced CT; Epithelial ovarian cancer; FDG PET CT; Recurrence; Second line chemotherapy; Secondary cytoreductive surgery

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EPITHELIAL OVARIAN CARCINOMA; FEMALE; FOLLOW UP; HUMAN; MULTIDETECTOR COMPUTED TOMOGRAPHY; OVARY CARCINOMA; PATIENT INFORMATION; PREDICTION; PREDICTIVE VALUE; RECURRENT CANCER; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; CARCINOMA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79956085510     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-010-1568-0     Document Type: Article

References (21)

1. Heintz A, Odicino F, Maisonneuve P, Beller U, Benedet JL, Creasman WT, Ngan HY, Sideri M, Pecorelli S (2001) Carcinoma of the ovary. J Epidemiol Biostat 6:107-138 (Pubitemid 33134081)
2. Ozols RF (2006) Systemic therapy for ovarian cancer: current status and new treatments. Semin Oncol 33(Suppl 6):3-11
3. Coakley FV, Choi PH, Gougoutas CA, Pothuri B, Venkatraman E, Chi D, Bergman A, Hricak H (2002) Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 223:495-499 (Pubitemid 34454332)
4. Pannu HK, Bristow RE, Montz FJ, Fishman EK (2003) Multidetector CT of peritoneal carcinomatosis from ovarian cancer. RadioGraphics 23:687-701 (Pubitemid 37431249)
5. Forstner R (2007) Radiographical staging of ovarian cancer: imaging findings and contribution of CT and MRI. Eur Radiol 17:3223-3235
6. Topuz E, Aydiner A, Saip P, Eralp Y, Tas F, Salihoglu Y, Tenekeci N (2000) Correlation of serum CA125 level and computerized tomography (CT) imaging with laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer. Eur J Gynaecol Oncol 21:599-602 (Pubitemid 32164827)
7. Zimny M, Siggelkow W, Schroder W, Nowak B, Biemann S, Buell U, Rath W (2001) 2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer. Gynecol Oncol 83:310-315
8. 18F)-FDG positron emission tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma. Eur J Radiol 10:761-767
9. Pannu HK, Cohade C, Bristow RE, Fishman EK, Wahl RL (2004) PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation. Abdom Imaging 39:398-403 (Pubitemid 38590822)
10. Bristow RE, Del Carmen MG, Pannu HK, Cohade C, Zahurak ML, Fishman EK, Wahl RL, Montz FJ (2003) Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol Oncol 90:519-528
11. Buy JN, Moss AA, Ghossain MA, Sciot C, Malbec L, Vadrot D, Paniel BJ, Decroix Y (1988) Peritoneal implants from ovarian tumors: CT findings. Radiology 169:691-694
12. Soussan M, Wartski M, Cherel P, Fourme E, Goupil A, Le Stanc E, Callet N, Alexandre J, Pecking AP, Alberini JL (2008) Impact of FDG PET-CT imaging on the decision making in the biologic suspicion of ovarian carcinoma recurrence. Gynecol Oncol 108:160-165 (Pubitemid 350299439)
13. Bristow RE, Giuntoli RL II, Pannu HK, Schulick RD, Fishman EK, Wahl RL (2005) Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes. Gynecol Oncol 99:294-300 (Pubitemid 41502833)
14. 18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings. Eur J Nucl Med Mol Imaging 34:480-486
15. Mangili G, Picchio M, Sironi S, Vigano R, Rabaiotti E, Bornaghi D, Bettinardi V, Crivellaro C, Messa C, Fazio F (2007) Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer. Eur J Nucl Med Mol Imaging 34:658-666 (Pubitemid 46669366)
16. Thrall MM, DeLoia JA, Gallion H, Avril N (2007) Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer. Gynecol Oncol 105:17-22 (Pubitemid 46441448)
17. Togashi K (2003) Ovarian cancer: the clinical role of US, CT, and MRI. Eur Radiol 13(Suppl 4):L87-L104
18. Makhija S, Howden N, Edwards R, Kelley J, Townsend DW, Meltzer CC (2002) Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review. Gynecol Oncol 85:53-58 (Pubitemid 34304010)
19. Martinez-Roman S, Ramirez PT, Oh J, Viciedo MG, MacApinlac HA (2005) Combined positron emission tomography and computed tomography for the detection of recurrent ovarian mucinous adenocarcinoma. Gynecol Oncol 96:888-891 (Pubitemid 40255522)
20. Simcock B, Neesham D, Quinn M, Drummond E, Milner A, Hicks RJ (2006) The impact of PET/CT in the management of recurrent ovarian cancer. Gynecol Oncol 103:271-276 (Pubitemid 44374699)
21. Mansueto M, Grimaldi A, Mangili G, Picchio M, Giovacchini G, Viganò R, Messa C, Fazio F (2009) Positron emission tomography/computed tomography introduction in the clinical management of patients with suspected recurrence of ovarian cancer: a cost-effectiveness analysis. Eur J Cancer Care 18:612-619